ResearcherAmsterdam University Medical CentersActive in the last 2 years
JanWillem Duitman
Matched on ORCID iD 0000-0003-4254-3380; OpenAlex author ID A5050066950. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper
Papers 8
- Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. Co-author DOI 10.3390/ijms25179449↗
- C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. Co-author DOI 10.3390/ijms24021537↗
- Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner. Last author DOI 10.3390/biomedicines10020219↗
- C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration. Co-author DOI 10.3390/cells11213334↗
- Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation. Co-author DOI 10.3390/biom11081079↗
- Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? First author DOI 10.3390/biology9040080↗
- CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcino… First author DOI 10.3390/cancers12092546↗
- Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance. Co-author DOI 10.1002/ijc.28726↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- C. Arnold Spek · 8 shared papers, 2014–2024 · strength 1.33
- Paper Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytid… DOI 10.3390/biomedicines10020219↗
- Paper Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. DOI 10.3390/ijms25179449↗
- Paper C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. DOI 10.3390/ijms24021537↗
- Maarten F. Bijlsma · 6 shared papers, 2020–2024 · strength 1.02
- Paper Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. DOI 10.3390/ijms25179449↗
- Paper C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. DOI 10.3390/ijms24021537↗
- Paper Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Fo… DOI 10.3390/biom11081079↗
- Leonie Hartl · 5 shared papers, 2020–2024 · strength 0.88
- Paper Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. DOI 10.3390/ijms25179449↗
- Paper C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. DOI 10.3390/ijms24021537↗
- Paper Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Fo… DOI 10.3390/biom11081079↗
- Frederike Dijk · 2 shared papers, 2020–2023 · strength 0.31
- Etienne J. Slapak · 1 shared paper, 2020 · strength 0.15
- Cansu Tekin · 1 shared paper, 2020 · strength 0.15
- Mark P.G. Dings · 1 shared paper, 2020 · strength 0.09
- Maikel Petrus Peppelenbosch · 1 shared paper, 2020 · strength 0.09
- Marc G. Besselink · 1 shared paper, 2020 · strength 0.09
- Dick J. Richel · 1 shared paper, 2014 · strength 0.04
- Johanna W. Wilmink · 1 shared paper, 2014 · strength 0.04
- Kun Shi · 1 shared paper, 2014 · strength 0.04
- Karla C. S. Queiroz · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.